New York State Approves Quest Diagnostics' Fragile X Syndrome TestAn accurate, faster testing option to identify female carriers and other patients with genetic abnormalities that cause Fragile X Syndrome is now available to physicians in all fifty states with the recent approval in New York. Fragile X is the leading cause of inherited mental retardation and the most common known single gene cause of autism...
Curemark Opens Autism Trials At New Jersey SiteCuremark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that Saint Peter's University Hospital in New Brunswick, New Jersey, is participating in the company's Phase III clinical trials for CM-AT, Curemark's autism treatment. Saint Peter's is affiliated with the Drexel University College of Medicine in Philadelphia...
Autism Charity Raises The Bar For Legal Campaigning, UKThe National Autistic Society (NAS) has ramped up its legal campaigning with the launch of a new Autism Legal Network and a call for cases with the potential to change the law for the half a million people with autism in the UK. Mark Lever, chief executive of the NAS said; "The NAS is evolving. Last year we successfully secured the landmark Autism Act...
Autism Detected In Unique Vocal Signature Of Baby Talk Using a new type of "vocal signature" technology that focuses on sound patterns rather than words in child vocalizations and baby talk, researchers in the US say they have proved in principle that it is possible to screen for autism spectrum disorders in young children; they also hope the new method will greatly enhance the study of language development because it...
New Technology Reveals A Unique Vocal Signature In AutismA new automated vocal analysis technology could fundamentally change the study of language development as well as the screening for autism spectrum disorders and language delay, reports a study in the July 19 online Proceedings of the National Academy of Sciences...
Closer To A Treatment For AutismRubicon winner Dalila Pinto discovered a copying error in the DNA of trial subjects who suffered from autism or a similar condition. Some segments of their DNA were copied either once too often or missed out of the copying process. This is a highly promising result from the world's largest investigation into autism. The top journal Nature placed the results online on 9 June...